Earnings · US stocks
Celldex Therapeutics, Inc. (CLDX) earnings
Celldex Therapeutics, Inc. published its quarterly report on 2026-11-05. The stock moved +8.42% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-05
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +5.66% | — |
| 3 days | +8.42% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +3.04%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-05 | -0.96 | +3.39% | +8.42% | — | — |
| 2026-08-06 | -0.94 | +11.41% | +6.67% | -7.99% | -7.09% |
| 2026-05-07 | -1.18 | -4.22% | -3.96% | +0.27% | -1.48% |
| 2026-02-25 | -1.22 | -22.50% | -2.66% | +9.09% | +11.00% |
| 2025-11-10 | -1.01 | -13.16% | +4.63% | +17.25% | +16.29% |
| 2025-08-07 | -0.85 | -0.96% | +12.21% | +16.03% | +11.06% |
| 2025-05-08 | -0.81 | -9.09% | +0.51% | +4.46% | -1.75% |
| 2025-02-27 | -0.71 | +0.64% | -1.53% | -21.52% | -11.18% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.